Biomea Fusion

Verified by our team

  • Biotech
Linkedin Twitter Facebook

Biomea Fusion is a biopharmaceutical company focused on discovering and developing oral covalent small molecules to treat metabolic diseases and genetically defined cancers. Their proprietary FUSION™ System enables the development of highly selective and durable treatments, with lead candidates targeting menin, FLT3, and GLP-1 receptors.

Biomea Fusion Highlights:

  • Biomea Fusion annual revenue is $7.8M.
  • Biomea Fusion total funding is $56.0M.
  • Biomea Fusion headquartered in Redwood City, California.
  • Biomea Fusion number of employees is 126.

    • Overview

    • Website: biomeafusion.com
    • Headquarters: Redwood City, California
    • Employees: 126
    • Founded: 2017
    • Email: info@biomeafusion.com
    • Funding: $56.0M
    • Revenue: $7.8M
    • Valuation: n/a

    Contacts

    Franco V

    CFO
    Linkedin
    • Email: ***@biomeafusion.com
    Buy the List to Unlock Contacts

    Similar companies

    Frequently Asked Questions related to Biomea Fusion

    Biomea Fusion is located in Redwood City, California.
    Yes, Biomea Fusion is a Silicon Valley company.
    Biomea Fusion total funding is 56.0M.
    Biomea Fusion revenue is 7.8M.
    Biomea Fusion’s number of employees is 126.
    Biomea Fusion’s CEO name is Franco V.
    Biomea Fusion was founded in 2017.
    Biomea Fusion’s contact email is info@biomeafusion.com.

    Follow Silicon Valley Journals

    Awarded by

    corporate vision magazine

    © Copyright 2022-2024 Silicon Valley Journals. All rights reserved.

    Fundings

    Quick links

    Company

    © Copyright SVJ Media Ltd., 71-75 Shelton Street. Covent Garden. London, GB WC2H 9JQ